Is Valtrex Safe During Pregnancy
Status
cautionReason
Limited human pregnancy data. Use only if benefit outweighs risk; consult your OB/GYN or prescriber.
Drug Information
Safe Amount
Dosage must be determined by your provider based on individual risk/benefit.
Effects
- Pregnancy
- Untreated genital herpes, especially late in pregnancy, can increase neonatal herpes risk. FDA notes risk is higher when HSV is acquired in late pregnancy.
- Mother
- May help treat or suppress herpes infections in pregnancy. Maternal toxicity is possible, especially with kidney problems or dehydration.
- Baby
- FDA labeling reports no identified drug-associated risk of major birth defects, but data are limited. Untreated herpes can also harm the newborn.
Trimester Notes
- 1st Trimester
- No clear increase in major birth defects has been identified, but data are limited.
- 2nd Trimester
- Limited data. Use only if needed and directed by your prescriber.
- 3rd Trimester
- Late-pregnancy HSV infection can raise newborn infection risk. Provider may recommend suppressive treatment near delivery.
Risk-Benefit Note
For antivirals, the risk of untreated herpes must be weighed against limited pregnancy safety data. Do not stop or start without provider guidance.
Conditions & Warnings
- Consult OB/GYN or prescriber
- Do not stop or continue without provider review
- Pregnancy registry data are limited
- Herpes simplex infection in pregnancy
- Kidney disease may raise side effects risk
Alternatives
- Acyclovir, if your prescriber recommends it
- Non-drug measures your OB/GYN recommends for herpes management
References
- FDA Valtrex (valacyclovir) label
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf - MotherToBaby/NCBI Bookshelf: Acyclovir/Valacyclovir
https://www.ncbi.nlm.nih.gov/books/NBK582557/ - FDA Valacyclovir label SPL
https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/275c0198-10a5-139e-e063-6394a90a72be/spl-doc?hl=valacyclovir